Molnupiravir (Lagevrio) is a potent ribonucleoside analog that blocks SARS-CoV-2 replication by acting as a competitive substrate of virally-encoded RNA-dependent RNA polymerase.
Kevin Nguyen, PharmD; Nathan Nguyen, PharmD Candidate; Mya Yee, PharmD Candidate; Katherine Kim, PharmD Candidate
Advertisement
Articles by Kevin Nguyen, PharmD; Nathan Nguyen, PharmD Candidate; Mya Yee, PharmD Candidate; Katherine Kim, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
4
Expert Insights on Key Data from IMS 2025
5
